China Health Technology Group Holding Company Limited

As of December 31, 2025, China Health Technology Group Holding Company Limited carries a market capitalization of 42.20M, placing it among publicly traded companies globally. Its enterprise value stands at 166.97M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, China Health Technology Group Holding Company Limited has 121.64M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, China Health Technology Group Holding Company Limited maintains a current ratio of 1.34, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on September 30, 2026, China Health Technology Group Holding Company Limited's stock has declined approximately 33.39% over the past 52 weeks. The 50-day moving average sits at 0.26, while the 200-day moving average is 0.32.

As of December 31, 2025, China Health Technology Group Holding Company Limited holds 2.89M in cash and equivalents against 127.66M in total debt, resulting in a net debt position of 124.37M. Total book value stands at 63.31M, with working capital of 11.47M providing operational flexibility.

China Health Technology Group Holding Company Limited's most recent stock split took place on May 14, 2026 with a 11:13 split ratio.